{"Nicotinate-nucleotide adenylyltransferase": 0, "Amyloid-beta precursor protein": 1, "Glycerophosphocholine phosphodiesterase GPCPD1": 2, "2,6-dichloro-p-hydroquinone 1,2-dioxygenase": 3, "cGMP-dependent 3',5'-cyclic phosphodiesterase": 4, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,K548C]": 5, "Mu-type opioid receptor": 6, "Beta-1 adrenergic receptor": 7, "Adenosine receptor A3 [I248L]": 8, "Muscarinic acetylcholine receptor M1": 9, "1-deoxy-D-xylulose-5-phosphate synthase": 10, "5-hydroxytryptamine receptor 7": 11, "Thymidine phosphorylase": 12, "Adenylate cyclase type 2": 13, "Isochorismatase family protein": 14, "Endothelin receptor type B": 15, "Glutamate receptor ionotropic, kainate 5": 16, "Corticoliberin": 17, "Peptidoglycan-N-acetylglucosamine deacetylase": 18, "Proteinase-activated receptor 2": 19, "Beta-secretase 1 [22-454]": 20, "Sphingosine 1-phosphate receptor 1": 21, "Aldo-keto reductase family 1 member C4": 22, "3-dehydroquinate synthase": 23, "Substance P": 24, "Hypoxanthine-guanine phosphoribosyltransferase": 25, "Glutaminyl-peptide cyclotransferase": 26, "N-formyl peptide receptor 2": 27, "Histone deacetylase 8": 28, "Alpha-synuclein": 29, "Gag-Pol polyprotein": 30, "Aldo-keto reductase family 1 member B1": 31, "Alpha-1B adrenergic receptor": 32, "Rho-associated protein kinase 2": 33, "Acyl-protein thioesterase 2 [P86Q]": 34, "Metallo-beta-lactamase VIM-2": 35, "Gamma-aminobutyric acid receptor subunit alpha-5": 36, "Chymotrypsinogen A": 37, "2''-aminoglycoside nucleotidyltransferase": 38, "Olfactory receptor 145": 39, "Isoform PNNOS of Nitric oxide synthase, brain (PNNOS) -973,I269V,M336V,D597N]": 40, "25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial": 41, "B1 bradykinin receptor": 42, "Cytochrome P450 3A4": 43, "Melanocyte-stimulating hormone receptor": 44, "Pro-neuropeptide Y": 45, "Caspase-5": 46, "Replicase polyprotein 1ab": 47, "Kappa-type opioid receptor [Y320A]": 48, "Leukotriene B4 receptor 1": 49, "VIM-24": 50, "Carbonic anhydrase 14": 51, "Peroxisome proliferator-activated receptor alpha": 52, "Protein kinase C theta type": 53, "Delta-aminolevulinic acid dehydratase": 54, "Aldehyde dehydrogenase, dimeric NADP-preferring": 55, "Tyrosine-protein phosphatase non-receptor type 11": 56, "Tyrosine-protein phosphatase non-receptor type 1 [1-301]": 57, "5-hydroxytryptamine receptor 1B": 58, "Interstitial collagenase": 59, "cAMP-specific 3',5'-cyclic phosphodiesterase 4D": 60, "Peptidyl-prolyl cis-trans isomerase H": 61, "Signal transducer and activator of transcription 5B": 62, "Beta-lactamase [24-383]": 63, "Cytochrome P450 3A2": 64, "Carbonic anhydrase 1": 65, "Endothelin-1 receptor": 66, "Excitatory amino acid transporter 2": 67, "Pro-thyrotropin-releasing hormone-B": 68, "Bifunctional dihydrofolate reductase-thymidylate synthase": 69, "Somatostatin receptor type 4": 70, "Gamma-aminobutyric acid receptor subunit alpha-2": 71, "Homoisocitrate dehydrogenase": 72, "ATP synthase subunit a": 73, "Thyrotropin-releasing hormone receptor": 74, "1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial": 75, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,L525I]": 76, "Poly(A)-specific ribonuclease PARN": 77, "Histamine H2 receptor": 78, "Kappa-type opioid receptor [D138A]": 79, "Glutamate receptor ionotropic, NMDA 2B": 80, "Somatostatin receptor type 2": 81, "Dimer of Gag-Pol polyprotein [489-587,Q496K,I573V]": 82, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,I551V]": 83, "Vasoactive intestinal polypeptide receptor 1": 84, "Disintegrin and metalloproteinase domain-containing protein 17 [215-477,S266A,N452Q]": 85, "Muscarinic acetylcholine receptor M3": 86, "Neuronal acetylcholine receptor subunit alpha-7": 87, "Dimer of Gag-Pol polyprotein [482-580,I502K,I528M,T553A]": 88, "Glutamate receptor 1": 89, "Histone deacetylase 6 [60-420]": 90, "Mitogen-activated protein kinase 1": 91, "Cytochrome P450 11B2, mitochondrial": 92, "Sodium channel subunit beta-3": 93, "Genome polyprotein [1027-1206,R1052K]": 94, "Uridine 5'-monophosphate synthase": 95, "Catenin beta-1 [138-686]": 96, "Carbonic anhydrase 5B, mitochondrial": 97, "Beta-2 adrenergic receptor": 98, "Cyclin-dependent kinase 2": 99, "Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,I543V,L552P,A560V,V571A,I573V,L579M]": 100, "Dimer of Gag-Pol polyprotein [491-589,Q498K,L501I,V555I,A562V,G564S,I575V,L581M]": 101, "Neuropeptide Y receptor type 2": 102, "Dimer of Gag-Pol polyprotein [490-588,L523I,E525D,M526I,I544V,L553H,H559K,V572F,L579M]": 103, "Beta-secretase 1": 104, "Adenosine receptor A2a": 105, "Mineralocorticoid receptor": 106, "Histidinol dehydrogenase, chloroplastic": 107, "Substance-P receptor": 108, "Nicotinic acetylcholine receptor": 109, "Dimer of Gag-Pol polyprotein [489-587,Q496K]": 110, "Histone deacetylase 3": 111, "Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]": 112, "Kappa-type opioid receptor [1-7]": 113, "Voltage-dependent N-type calcium channel subunit alpha-1B": 114, "Outer capsid protein sigma-1": 115, "Gag-Pol polyprotein [489-587,G537V,H558K,V571A]": 116, "Angiopoietin-1 receptor": 117, "Purine nucleoside phosphorylase": 118, "Kappa-type opioid receptor [Q115A]": 119, "Bromodomain-containing protein 4 [352-457]": 120, "Beta-3 adrenergic receptor": 121, "Cyclin-dependent kinase 7": 122, "Platelet-derived growth factor receptor alpha": 123, "Neuronal acetylcholine receptor subunit alpha-4": 124, "Genome polyprotein": 125, "Tyrosine-protein kinase Fgr": 126, "Serine protease hepsin": 127, "D1 dopamine receptor": 128, "Histamine receptor H3": 129, "Insulin receptor": 130, "Chymase": 131, "ALK tyrosine kinase receptor": 132, "Coagulation factor XI": 133, "Histone deacetylase 6": 134, "Prephenate dehydrogenase": 135, "Melanocortin receptor 5": 136, "Progesterone receptor": 137, "72 kDa type IV collagenase": 138, "Mitogen-activated protein kinase 10": 139, "Glutamine--fructose-6-phosphate transaminase (isomerizing)": 140, "Histamine H1 receptor": 141, "Neuronal acetylcholine receptor subunit alpha-5": 142, "Aldehyde oxidase 1": 143, "Gastrin-releasing peptide": 144, "Trans-sialidase": 145, "Tyrosine-protein kinase ABL1": 146, "Kappa-type opioid receptor [M142A]": 147, "Uracil-DNA glycosylase": 148, "Orexin receptor type 2": 149, "Glycine receptor subunit alpha-1": 150, "Pepsin A": 151, "Transcription initiation factor IIA subunit 1": 152, "VIP peptides": 153, "Aldo-keto reductase family 1 member B1 [C299A]": 154, "Baculoviral IAP repeat-containing protein 3": 155, "Beta-mannosidase": 156, "Carbonic anhydrase 15 [19-324]": 157, "Intermediate conductance calcium-activated potassium channel protein 4": 158, "Translocator protein": 159, "Glutamate receptor 2": 160, "Suppressor of tumorigenicity 14 protein": 161, "Serotonin N-acetyltransferase": 162, "Pyrazinamidase/nicotinamidase PncA": 163, "Apoptosis regulator Bcl-2": 164, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T556C]": 165, "Melanocortin receptor 3": 166, "5-hydroxytryptamine receptor 2B": 167, "Cathepsin H": 168, "5-hydroxytryptamine receptor 2C": 169, "Coagulation factor IX": 170, "Plasmepsin IV": 171, "Macrophage-stimulating protein receptor": 172, "Protein lifeguard 1": 173, "TYR_PHOSPHATASE_2 domain-containing protein": 174, "Oxysterols receptor LXR-beta": 175, "Homeobox C9": 176, "Transducer protein Htr4": 177, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,G574S]": 178, "E3 ubiquitin-protein ligase Mdm2": 179, "Myosin light chain kinase 3": 180, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q]": 181, "Sulfotransferase 1A1": 182, "Beta-lactamase SHV-1": 183, "A disintegrin and metalloproteinase with thrombospondin motifs 5": 184, "Caspase-1": 185, "Sodium channel protein type 2 subunit alpha": 186, "Peripheral-type benzodiazepine receptor-associated protein 1": 187, "Complex of Sliding-clamp-loader large subunit [R175L] and Sliding-clamp-loader small subunit": 188, "Dimer of Gag-Pol polyprotein [489-587,L565M]": 189, "Indoleamine 2,3-dioxygenase 1": 190, "Putative choline uptake ABC transporter permease protein": 191, "Dimer of Gag-Pol polyprotein [489-587,L499I,L508Q,K509R,E524D,M525I,S526N,M535I,I539V,I543V,I551V,L552P,A560V,V571A,L579M]": 192, "Sodium/potassium-transporting ATPase subunit alpha-1": 193, "Matrix metalloproteinase-14": 194, "cAMP-dependent protein kinase": 195, "Serine/threonine-protein kinase PAK 4": 196, "Neuromedin-B receptor": 197, "Pro-thyrotropin-releasing hormone": 198, "Probable UDP-galactopyranose mutase": 199, "Solute carrier organic anion transporter family member 1B1": 200, "Solute carrier organic anion transporter family member 2A1": 201, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A]": 202, "Potassium voltage-gated channel subfamily H member 8": 203, "Small conductance calcium-activated potassium channel protein 1": 204, "Adenosine 3'-phospho 5'-phosphosulfate transporter 1": 205, "Dimer of Gag-Pol polyprotein [491-589,Q496K]": 206, "Prostaglandin E2 receptor EP3 subtype": 207, "P2Y purinoceptor 2": 208, "Melanin-concentrating hormone receptor 1": 209, "Neurotensin receptor type 1": 210, "Dimer of Gag-Pol polyprotein [501-599,D531N,M537I,A572V]": 211, "Type-2 angiotensin II receptor": 212, "Protein arginine N-methyltransferase 8": 213, "Kappa-type opioid receptor [I316A]": 214, "Gag-Pol polyprotein [484-582,Q491K,I494L,I497V,V499I,E519D,I534V,R541K,D544E,Q553K,A555V,L573M]": 215, "Cathepsin L2": 216, "fMet-Leu-Phe receptor": 217, "Peroxisome proliferator-activated receptor delta": 218, "Kinesin-like protein KIF11": 219, "Dihydrolipoyl dehydrogenase": 220, "Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,I573V,L579M,I582L]": 221, "Angiotensin-converting enzyme 2": 222, "Melatonin receptor type 1B": 223, "Dimer of Gag-Pol polyprotein [491-589,Q498K,D521N,V555I,N579D]": 224, "Non-secretory ribonuclease": 225, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T552C]": 226, "Adenosine receptor A1": 227, "Pteridine reductase": 228, "Dimer of Gag-Pol polyprotein [514-612]": 229, "Prostaglandin G/H synthase 2": 230, "Rat vasopressin-neurophysin": 231, "Complex of Baculoviral IAP repeat-containing protein 7 [1-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]": 232, "Sodium-dependent dopamine transporter": 233, "Kappa-type opioid receptor": 234, "Baculoviral IAP repeat-containing protein 3 [255-322]": 235, "Retinoic acid receptor RXR-alpha": 236, "3-oxoacyl-[acyl-carrier-protein] synthase 1 [C171Q]": 237, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,F550C]": 238, "Cathepsin D": 239, "Tyrosine-protein phosphatase non-receptor type 2": 240, "Aspartate--tRNA ligase": 241, "Melatonin receptor type 1A": 242, "NAD kinase": 243, "Bacterial leucyl aminopeptidase": 244, "Complement C1s subcomponent": 245, "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1": 246, "Cholinergic receptor, nicotinic alpha 1": 247, "Tyrosine-protein kinase FRK": 248, "Kappa-type opioid receptor [M226A]": 249, "Ephrin type-B receptor 2": 250, "Protein-glutamine gamma-glutamyltransferase 2": 251, "Cyclin-dependent kinase 1": 252, "Vasopressin V1a receptor": 253, "Platelet-derived growth factor receptor beta": 254, "Hepatocyte growth factor receptor [1078-1345,Y1230H,L1272V]": 255, "Cholecystokinin receptor type A": 256, "Glutamate receptor ionotropic, kainate 1": 257, "Thymidine kinase": 258, "Epidermal growth factor receptor": 259, "Tyrosine-protein kinase Fyn": 260, "cAMP-dependent protein kinase catalytic subunit beta": 261, "Acyl-protein thioesterase 2 [L78I,A85S]": 262, "Peroxisome proliferator-activated receptor gamma": 263, "Beta-arrestin-1": 264, "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4": 265, "Bombesin": 266, "Tyrosine-protein phosphatase non-receptor type 9": 267, "Pro-epidermal growth factor": 268, "Androgen receptor": 269, "Beta-nerve growth factor": 270, "Alpha-2C adrenergic receptor": 271, "Glutamate receptor ionotropic, kainate 3": 272, "Serine/threonine-protein kinase PLK2": 273, "Inosine-5'-monophosphate dehydrogenase 2": 274, "Pro-glucagon": 275, "Acyl-protein thioesterase 2 [M178L]": 276, "Solute carrier organic anion transporter family member 1B3": 277, "cGMP-dependent protein kinase 1": 278, "Complex of Sliding-clamp-loader large subunit [R175K] and Sliding-clamp-loader small subunit": 279, "Dimer of Gag-Pol polyprotein [501-599,D531N,A572V]": 280, "Cysteinyl leukotriene receptor 1": 281, "5-hydroxytryptamine receptor 4": 282, "Aminopeptidase N": 283, "Glycylpeptide N-tetradecanoyltransferase": 284, "Peptidyl-prolyl cis-trans isomerase-like 1": 285, "Alpha-bungarotoxin": 286, "Dimer of Gag-Pol polyprotein [489-587,I539V]": 287, "Lysine-specific demethylase 5A": 288, "Gamma-hydroxybutyrate receptor": 289, "Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]": 290, "Dihydrofolate reductase": 291, "Vascular endothelial growth factor receptor 2": 292, "Enteropeptidase": 293, "Signal transducer and activator of transcription 5A": 294, "Carbonic anhydrase 13": 295, "Histone H1.0": 296, "Serine/threonine-protein kinase pim-2": 297, "Beta-lactamase CTX-M-1": 298, "Cathepsin B": 299, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,I585V]": 300, "Cyclin-dependent kinase 9": 301, "Tyrosine-protein phosphatase non-receptor type 22": 302, "Fibroblast growth factor receptor 1": 303, "Kappa-type opioid receptor [Y66A]": 304, "Aldo-keto reductase family 1 member C1 [L306A]": 305, "Retinoic acid receptor gamma [183-417]": 306, "Nitric oxide synthase, brain": 307, "Lipoxygenase": 308, "Prokineticin receptor 1": 309, "Mandelate racemase": 310, "Apamin": 311, "Melatonin receptor type 1C": 312, "C-C chemokine receptor type 3": 313, "Gamma-aminobutyric acid receptor subunit alpha-4": 314, "Aurora kinase B": 315, "Hypoxanthine-guanine-xanthine phosphoribosyltransferase": 316, "Nischarin": 317, "Probable glutamate--tRNA ligase, mitochondrial": 318, "Disintegrin and metalloproteinase domain-containing protein 17": 319, "Hypoxanthine phosphoribosyltransferase": 320, "G-protein coupled estrogen receptor 1": 321, "Inner capsid protein sigma-2": 322, "5-hydroxytryptamine 1D receptor": 323, "Serine/threonine-protein kinase MRCK beta": 324, "Metabotropic glutamate receptor 4": 325, "Adrenergic alpha2 receptor": 326, "P2X purinoceptor 4": 327, "Enoyl-[acyl-carrier-protein] reductase [NADH]": 328, "Polyunsaturated fatty acid 5-lipoxygenase": 329, "Alpha-2A adrenergic receptor [16-465]": 330, "Delta-type opioid receptor": 331, "Glucocorticoid receptor": 332, "Type-1 angiotensin II receptor B": 333, "Lethal factor": 334, "Cannabinoid receptor 1": 335, "Serine/threonine-protein kinase B-raf": 336, "Protein kinase C gamma type": 337, "Amine oxidase [flavin-containing] A": 338, "Dimer of Gag-Pol polyprotein [491-589,Q498K,L501I,G539V,I545V,V555I,V573A]": 339, "Melanocortin receptor 4": 340, "Acyl-protein thioesterase 1": 341, "Dual specificity protein phosphatase 3": 342, "Gag-Pol polyprotein [484-582,I497V,V499I,E519D,G532V,I538V,R541K,D544E,Q553K,V566A,L573M]": 343, "Gamma-aminobutyric acid receptor subunit alpha-6": 344, "HIV-1 protease": 345, "Caspase-8": 346, "P2X purinoceptor": 347, "eIF-2-alpha kinase GCN2": 348, "DNA polymerase III PolC-type": 349, "Probable nicotinate-nucleotide adenylyltransferase": 350, "Protachykinin-1": 351, "Gag-Pol polyprotein [484-582,I494L,I497V,V499I,D514N,E519D,R541K,D544E,Q553K,N572D,L573M]": 352, "Lysosomal Pro-X carboxypeptidase": 353, "Neuropeptide FF receptor 2": 354, "Tyrosine-protein kinase BTK": 355, "Hemagglutinin": 356, "A disintegrin and metalloproteinase with thrombospondin motifs 4": 357, "Neuronal acetylcholine receptor subunit alpha-3": 358, "5-hydroxytryptamine receptor 1A": 359, "Carboxylic ester hydrolase": 360, "Tryptase beta-2": 361, "Melatonin receptor": 362, "neuronal acetylcholine receptor subunit alpha-4": 363, "Thromboxane A2 receptor": 364, "Equilibrative nucleoside transporter 1": 365, "Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,L552P,A560V,V571A,L579M]": 366, "Vasoactive intestinal polypeptide receptor 2": 367, "Dual specificity tyrosine-phosphorylation-regulated kinase 1A": 368, "Oxa40": 369, "Kappa-type opioid receptor [Y119F]": 370, "Orexin/Hypocretin receptor type 1": 371, "Mitogen-activated protein kinase 8": 372, "Progonadoliberin-1": 373, "Glutamine--tRNA ligase": 374, "Alpha-2A adrenergic receptor": 375, "Adenosine receptor A3": 376, "Protein kinase C alpha type": 377, "Aldo-keto reductase family 1 member C2": 378, "Beta-secretase 1 [22-457]": 379, "Glycine--tRNA ligase": 380, "Dimer of Gag-Pol polyprotein [501-599,A572V,V583T,I585V]": 381, "Glycine amidinotransferase, mitochondrial": 382, "Metabotropic glutamate receptor 1": 383, "Aldo-keto reductase family 1 member B1 [W220Y,C299A]": 384, "Ketol-acid reductoisomerase (NADP(+))": 385, "Plasma kallikrein": 386, "Prolactin-releasing peptide receptor": 387, "Dimer of Gag-Pol polyprotein [489-587,L512V]": 388, "Fatty acid-binding protein, intestinal": 389, "Protease": 390, "Collagenase 3": 391, "Tubulin--tyrosine ligase": 392, "Isoform Alpha-4-2 of Neuronal acetylcholine receptor subunit alpha-4 (Alpha-4-2)": 393, "E3 ubiquitin-protein ligase XIAP [241-356]": 394, "Gastrin/cholecystokinin type B receptor": 395, "Platelet-activating factor receptor": 396, "Dimer of Gag-Pol polyprotein [489-587,V571I]": 397, "Solute carrier family 22 member 2": 398, "Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]": 399, "Dipeptidyl peptidase 8": 400, "Beta-secretase 2": 401, "Mitogen-activated protein kinase kinase kinase 14": 402, "Isoleucine--tRNA ligase": 403, "cholinergic receptor, nicotinic, alpha 1 (Muscle) isoform X1": 404, "Acyl-protein thioesterase 2 [H152R]": 405, "4-hydroxy-tetrahydrodipicolinate reductase": 406, "Deoxyuridine 5'-triphosphate nucleotidohydrolase": 407, "Peptidyl-prolyl cis-trans isomerase B": 408, "Rho-associated protein kinase 2 [11-552]": 409, "P2Y purinoceptor 1": 410, "Nitric oxide synthase, brain [D597N,M336V]": 411, "Tumor necrosis factor": 412, "Casein kinase II subunit alpha": 413, "Glycogen synthase kinase-3 alpha": 414, "Beta-arrestin-2": 415, "Fatty acid-binding protein, liver [T94A]": 416, "Gag-Pol polyprotein [484-582,I494L,I497V,V499I,E519D,I534V,R541K,D544E,Q553K,A555V,L573M]": 417, "Carbonic anhydrase 6": 418, "Opioid receptor delta 1": 419, "Serine/threonine-protein kinase pim-1": 420, "Prostaglandin E2 receptor EP4 subtype": 421, "Histone deacetylase 6 [84-835]": 422, "Vitamin K epoxide reductase complex subunit 1": 423, "AP-4 complex subunit sigma-1": 424, "Sodium-dependent serotonin transporter": 425, "Substance-K receptor": 426, "Adenosine kinase": 427, "Polyphenol oxidase 2": 428, "Galanin peptides": 429, "Pancreatic polypeptide receptor 1": 430, "Xanthine-guanine phosphoribosyltransferase": 431, "Capsid scaffolding protein": 432, "Neuraminidase": 433, "Homoserine kinase": 434, "Opioid growth factor receptor-like protein 1": 435, "Diacylglycerol O-acyltransferase 1": 436, "Nociceptin receptor": 437, "Hrh3 protein": 438, "Poly [ADP-ribose] polymerase 1": 439, "Ribosomal protein S6 kinase alpha-1": 440, "Fatty-acid amide hydrolase 1 [30-579]": 441, "Kappa-type opioid receptor [Y320F]": 442, "Protein arginine N-methyltransferase 6": 443, "Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A)": 444, "Carboxypeptidase B2": 445, "Histamine H4 receptor": 446, "Xanthine dehydrogenase/oxidase": 447, "Dimer of Gag-Pol polyprotein [489-587]": 448, "Adenylate cyclase type 3": 449, "P2X purinoceptor 2": 450, "Sodium- and chloride-dependent glycine transporter 2": 451, "Neuronal acetylcholine receptor subunit alpha-6": 452, "Cell division cycle 7-related protein kinase": 453, "Kappa-type opioid receptor [D138N]": 454, "Ribosomal protein S6 kinase alpha-5": 455, "Potassium voltage-gated channel subfamily H member 2": 456, "Ephrin type-B receptor 1": 457, "Transient receptor potential cation channel subfamily V member 1": 458, "Metabotropic glutamate receptor 7": 459, "EEF1AKMT4-ECE2 readthrough transcript protein": 460, "Kappa-type opioid receptor [H291A]": 461, "Glycogen phosphorylase, muscle form": 462, "Coagulation factor X": 463, "Estrogen receptor beta": 464, "Dimer of Gag-Pol polyprotein [489-587,V521I]": 465, "cAMP-dependent protein kinase catalytic subunit alpha": 466, "Glutamate receptor ionotropic, kainate 4": 467, "Heat shock 70 kDa protein 1A": 468, "D(1B) dopamine receptor": 469, "B2 bradykinin receptor": 470, "Thyroid hormone receptor beta": 471, "Growth hormone secretagogue receptor type 1": 472, "Ephrin type-B receptor 4": 473, "Chitinase B": 474, "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1": 475, "Tyrosine-protein phosphatase non-receptor type 1": 476, "DNA-(apurinic or apyrimidinic site) endonuclease": 477, "Trace amine-associated receptor 1": 478, "Arachidonate 5-lipoxygenase-activating protein": 479, "Promotilin": 480, "Mitogen-activated protein kinase 14": 481, "Peptide deformylase": 482, "Peptidyl-prolyl cis-trans isomerase A": 483, "Aldo-keto reductase family 1 member C3": 484, "Sodium channel protein type 9 subunit alpha": 485, "Cholinergic receptor nicotinic alpha 6 subunit": 486, "Acid phosphatase": 487, "Inosine-5'-monophosphate dehydrogenase 1": 488, "Serum paraoxonase/arylesterase 1": 489, "Kininogen-1": 490, "Gamma-aminobutyric acid receptor subunit alpha-3": 491, "Cytochrome P450 2A6": 492, "Neutrophil elastase": 493, "Tyrosine-protein phosphatase non-receptor type 7": 494, "Dual specificity protein phosphatase 22": 495, "Dihydroorotate dehydrogenase (quinone), mitochondrial": 496, "Glutamate metabotropic receptor 5": 497, "Carboxypeptidase A1": 498, "S-methyl-5'-thioinosine phosphorylase": 499, "Low molecular weight phosphotyrosine protein phosphatase": 500, "Glutamate metabotropic receptor 1": 501, "Lysosomal acid glucosylceramidase": 502, "5'-nucleotidase": 503, "5-hydroxytryptamine receptor 1F": 504, "Ret proto-oncogene": 505, "Aldo-keto reductase family 1 member C1": 506, "Adenylate cyclase type 9": 507, "Acyl-protein thioesterase 2 [L78I]": 508, "Receptor-type tyrosine-protein kinase FLT3": 509, "Kappa-type opioid receptor [I294A]": 510, "Acyl-protein thioesterase 1 [I75L]": 511, "Adenosine receptor A2b": 512, "Fatty acid synthase [2202-2509]": 513, "Dipeptidyl peptidase 9": 514, "Gamma-aminobutyric acid receptor subunit rho-3": 515, "Dimer of Gag-Pol polyprotein [501-599,D531N,M537I]": 516, "Tissue-type plasminogen activator": 517, "AP-3 complex subunit sigma-2": 518, "Pituitary adenylate cyclase-activating polypeptide": 519, "Tyrosine-protein kinase JAK2": 520, "Casein kinase I isoform alpha": 521, "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform": 522, "Polyamine deacetylase HDAC10": 523, "Sodium- and chloride-dependent glycine transporter 1": 524, "CARBONIC ANHYDRASE": 525, "Tyrosine-protein kinase CSK": 526, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,K178C]": 527, "Endochitinase B1": 528, "Ribosomal protein S6 kinase alpha-3": 529, "Muscarinic acetylcholine receptor": 530, "Neuronal acetylcholine receptor subunit beta-4": 531, "Sodium channel protein type 1 subunit alpha": 532, "Neurotensin receptor 1": 533, "Beta-galactosidase": 534, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T553C]": 535, "Casein kinase I isoform delta": 536, "Amine oxidase [flavin-containing] B [I199F]": 537, "Vitamin K-dependent protein C": 538, "S-adenosylmethionine synthase isoform type-2": 539, "Kappa-type opioid receptor [E297A]": 540, "Acidic mammalian chitinase": 541, "Tyrosine-protein kinase Lck": 542, "Prostaglandin E2 receptor EP1 subtype": 543, "Cyclin-dependent kinase 4": 544, "Angiotensinogen": 545, "C-C chemokine receptor type 2": 546, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,A177C]": 547, "D(3) dopamine receptor": 548, "Galanin receptor type 1": 549, "DNA ligase 1": 550, "Nicotinamidase": 551, "4-aminobutyrate aminotransferase, mitochondrial": 552, "Prostaglandin F2-alpha receptor": 553, "GABA(A) receptor-associated protein": 554, "Excitatory amino acid transporter 3": 555, "Endothelin-converting enzyme 1": 556, "Kinesin-like protein KIF11 [A356T]": 557, "Cyclin-dependent kinase 5": 558, "Prostaglandin D2 receptor 2": 559, "Kappa-type opioid receptor [K200A]": 560, "Membrane-associated progesterone receptor component 1": 561, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T180C]": 562, "Macrophage metalloelastase": 563, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,D531N]": 564, "GTP-binding nuclear protein GSP1/CNR1": 565, "Serine/threonine-protein kinase MRCK alpha": 566, "Glutamate receptor ionotropic, NMDA 1": 567, "Calpain-2 catalytic subunit": 568, "Aldo-keto reductase family 1 member B1 [K65Q]": 569, "Caspase-7": 570, "Sortilin": 571, "Quinone-dependent D-lactate dehydrogenase": 572, "Glutamine synthetase": 573, "Dimer of Gag-Pol polyprotein [489-587,M535I,L552P,A560V,V571F,I573V]": 574, "Glutamate receptor": 575, "Ionotropic glutamate receptor subunit Delta2": 576, "Protein kinase C": 577, "Prostaglandin E synthase": 578, "Beta-hexosaminidase subunit beta": 579, "Pro-FMRFamide-related neuropeptide FF": 580, "Aldo-keto reductase family 1 member C1 [L308A]": 581, "Lipopolysaccharide-induced tumor necrosis factor-alpha factor": 582, "Prostaglandin E2 receptor EP2 subtype": 583, "Class E basic helix-loop-helix protein 22": 584, "Urotensin-2 receptor": 585, "ATP-dependent translocase ABCB1": 586, "Macrophage migration inhibitory factor": 587, "Genome polyprotein [1027-1711]": 588, "Thymidylate synthase": 589, "Streptopain": 590, "Carboxypeptidase B": 591, "1-aminocyclopropane-1-carboxylate oxidase 1": 592, "Matrix metalloproteinase-9": 593, "Carbonic anhydrase 3": 594, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T549C]": 595, "Insulin receptor substrate 1": 596, "Somatostatin": 597, "Gamma-aminobutyric acid type B receptor subunit 1": 598, "Adenosylhomocysteine nucleosidase": 599, "Dopamine receptor D4": 600, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,V583A]": 601, "Prostaglandin-H2 D-isomerase": 602, "Pancreatic alpha-amylase": 603, "Melanin-concentrating hormone receptor 2": 604, "Orotate phosphoribosyltransferase": 605, "Serine/threonine-protein kinase PLK1": 606, "Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,M535I,I543V,L552P,A560V,V571A,I573V,L579M]": 607, "Neuropeptide Y receptor type 5": 608, "Glutamate decarboxylase 2": 609, "G_PROTEIN_RECEP_F1_2 domain-containing protein": 610, "Protein O-GlcNAcase": 611, "Putative farnesyl pyrophosphate synthase": 612, "Eledoisin": 613, "Acyl-protein thioesterase 1 [Q83P]": 614, "Leukotriene A-4 hydrolase": 615, "cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B": 616, "Aurora kinase C": 617, "Dipeptidyl peptidase 1": 618, "Metabotropic glutamate receptor 8": 619, "Neuromedin-K receptor": 620, "Interleukin-18": 621, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,R179C]": 622, "Phosphoribosylglycinamide formyltransferase": 623, "kappa-type opioid receptor isoform 1": 624, "Porphobilinogen deaminase": 625, "Dimer of Gag-Pol polyprotein [489-587,Q496K,L499I,M525I,S526D,M535I,R546K,L552P,A560V,G562S,L579M,I582L]": 626, "Carbonic anhydrase 2": 627, "Ribosomal protein S6 kinase alpha-6": 628, "Receptor-type tyrosine-protein phosphatase F": 629, "Glutamate receptor ionotropic, kainate 2": 630, "Neuronal acetylcholine receptor subunit alpha-2": 631, "Angiogenin": 632, "Phosphoenolpyruvate carboxykinase, cytosolic [GTP]": 633, "Enoyl-[acyl-carrier-protein] reductase [NADH] [T276S]": 634, "Hepatocyte growth factor receptor [1078-1345,H1094R,L1272V]": 635, "Transporter": 636, "Chloride channel protein 1": 637, "Caspase-9": 638, "Caspase-6": 639, "Acetylcholinesterase": 640, "Bifunctional ligase/repressor BirA": 641, "Receptor activity-modifying protein 1": 642, "Serine/threonine-protein kinase PLK3": 643, "Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2": 644, "Trifunctional purine biosynthetic protein adenosine-3": 645, "Kappa-type opioid receptor [Y313A]": 646, "Serine/threonine-protein kinase PLK4": 647, "Non-receptor tyrosine-protein kinase TYK2": 648, "Peptidyl-prolyl cis-trans isomerase C": 649, "P2X purinoceptor 7": 650, "Ribonuclease pancreatic": 651, "Sphingosine 1-phosphate receptor 5": 652, "ORF1a": 653, "Acyl-protein thioesterase 2 [L78I,A85S,P86Q,H152R,R153A,A154S]": 654, "Sphingosine 1-phosphate receptor 4": 655, "Carbonic anhydrase 4": 656, "Oxoeicosanoid receptor 1": 657, "Complement C1r subcomponent": 658, "Neuropeptides B/W receptor type 1": 659, "Glutamate--tRNA ligase": 660, "Gamma-aminobutyric acid receptor subunit alpha-1": 661, "Dimer of Gag-Pol polyprotein [489-587,I539L]": 662, "Galanin receptor type 2": 663, "6-phosphogluconate dehydrogenase, decarboxylating": 664, "Platelet-derived growth factor subunit A": 665, "Bcl-2-like protein 1": 666, "Thromboxane-A synthase": 667, "FMRFamide-like neuropeptides 14": 668, "Cathepsin S": 669, "Hepatocyte growth factor receptor [1078-1345,D1228H,L1272V]": 670, "Glutamate receptor 3": 671, "Phosphotransferase": 672, "Histone-lysine N-methyltransferase, H3 lysine-79 specific": 673, "Interleukin-1 alpha": 674, "Sigma non-opioid intracellular receptor 1": 675, "DNA polymerase III subunit tau": 676, "GLRA1 protein": 677, "Tyrosine-protein kinase Blk": 678, "Coagulation factor VII": 679, "cAMP-specific 3',5'-cyclic phosphodiesterase 4B": 680, "Papain": 681, "Glycogen synthase kinase-3 beta": 682, "Type-1 angiotensin II receptor": 683, "Transducer protein HtrVI": 684, "dCTP deaminase": 685, "Muscarinic acetylcholine receptor M2": 686, "Heat shock protein HSP 90-alpha": 687, "Dimer of Gag-Pol polyprotein [489-587,I536L]": 688, "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase": 689, "Stromelysin-2": 690, "Kappa-type opioid receptor [K212A]": 691, "RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]": 692, "Inositol-tetrakisphosphate 1-kinase": 693, "Dimer of Gag-Pol polyprotein [501-599,M537I,A572V]": 694, "Beta-galactosidase [V151I,I185V]": 695, "ATP-sensitive inward rectifier potassium channel 1": 696, "Proto-oncogene tyrosine-protein kinase Src": 697, "P2X purinoceptor 1": 698, "D(4) dopamine receptor": 699, "AP-2 complex subunit sigma": 700, "Neprilysin": 701, "Histone deacetylase 1": 702, "17-beta-hydroxysteroid dehydrogenase type 1": 703, "Rho-associated protein kinase 1": 704, "5-hydroxytryptamine receptor 1E": 705, "Muscarinic acetylcholine receptor M4": 706, "Histamine receptor H4": 707, "Serine/threonine-protein kinase Chk1": 708, "Beta-glucuronidase": 709, "Dimer of Gag-Pol polyprotein [490-588,L523I,E525D,M526I,I544V,L553H,H559K,L579M]": 710, "Serine protease 1": 711, "DNA polymerase alpha subunit B": 712, "Tyrosine-protein kinase JAK3": 713, "L-lactate dehydrogenase": 714, "Peptidyl-prolyl cis-trans isomerase D": 715, "Matrilysin": 716, "cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A": 717, "Carbamoyl-phosphate synthase small chain": 718, "Interleukin-1 beta": 719, "Dual specificity protein phosphatase CDC14A": 720, "GTP-binding nuclear protein GSP2/CNR2": 721, "Pyroglutamylated RF-amide peptide receptor": 722, "P2X purinoceptor 3": 723, "Vasopressin V1b receptor": 724, "Protein arginine N-methyltransferase 1 [11-371]": 725, "Dimer of Growth hormone secretagogue receptor type 1": 726, "Neurotensin/neuromedin N": 727, "Carbonic anhydrase 7": 728, "Sulfotransferase 2A1": 729, "Vasopressin V2 receptor": 730, "Methionine aminopeptidase 2": 731, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,R551C]": 732, "Kappa-type opioid receptor [Y313F]": 733, "Leukotriene B4 receptor 2": 734, "Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A": 735, "Natriuretic peptides A": 736, "Carbonic anhydrase 5A, mitochondrial": 737, "Carbonic anhydrase 12": 738, "Replicase polyprotein 1ab [1541-1855]": 739, "Protein kinase C delta type": 740, "Thioredoxin reductase": 741, "Alpha-1D adrenergic receptor": 742, "Glutaminyl-peptide cyclotransferase-like protein": 743, "5-hydroxytryptamine receptor 2C isoform A": 744, "Somatostatin receptor type 5": 745, "Kappa-type opioid receptor [H291F]": 746, "Serine/threonine-protein kinase mTOR": 747, "Bis(5'-adenosyl)-triphosphatase": 748, "Cysteinyl leukotriene receptor 2": 749, "Platelet-derived growth factor subunit B": 750, "Pyrazinamidase/nicotinamidase, PncA protein": 751, "neuronal acetylcholine receptor subunit alpha-2": 752, "Chymotrypsin-C": 753, "Cholecystokinin": 754, "Norepinephrine transporter": 755, "5-hydroxytryptamine receptor 1D": 756, "Acyl-protein thioesterase 2": 757, "ATP-binding cassette sub-family C member 2": 758, "Alpha-2B adrenergic receptor": 759, "Prostaglandin D2 receptor": 760, "Procathepsin L": 761, "Urokinase plasminogen activator surface receptor": 762, "Dimer of Gag-Pol polyprotein [501-599,M537I]": 763, "Adenosine receptor A2": 764, "Acyl-protein thioesterase 1 [I75L,S82A]": 765, "Stromelysin-1": 766, "Dimer of Gag-Pol polyprotein [482-580,I502K,I528M,T553A,V564F]": 767, "Leucine-rich repeat serine/threonine-protein kinase 2": 768, "Alpha-methylacyl-CoA racemase": 769, "Amine oxidase": 770, "Oxaloacetate decarboxylase": 771, "Myeloperoxidase": 772, "Dimer of Gag-Pol polyprotein [489-587,L512I]": 773, "Acylase": 774, "cAMP-specific 3',5'-cyclic phosphodiesterase 4A": 775, "Serine/threonine-protein kinase ATR": 776, "Fatty-acid amide hydrolase 1": 777, "Kappa-type opioid receptor [Y139F]": 778, "Gag-Pol polyprotein [484-582,Q491K,I494L,I497V,V499I,E519D,R541K,D544E,Q553K,L573M]": 779, "Caspase-3": 780, "Isoform PDE10A2 of cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (PDE10A2)": 781, "S-methyl-5'-thioadenosine phosphorylase": 782, "Calcitonin gene-related peptide type 1 receptor": 783, "Carbonic anhydrase 2 [A65S,N67Q,E69T,I91L,F131V,K170E,L204A]": 784, "Prostaglandin G/H synthase 1": 785, "Arginase": 786, "Hepatocyte growth factor receptor [1078-1345,V1092I,L1272V]": 787, "Bifunctional dihydrofolate reductase-thymidylate synthase [N51I,C59R,S108N,I164L]": 788, "11-beta-hydroxysteroid dehydrogenase 1": 789, "Cathepsin K": 790, "Dimer of Gag-Pol polyprotein [489-587,V571A]": 791, "1-deoxy-D-xylulose 5-phosphate reductoisomerase": 792, "Somatostatin receptor type 1": 793, "Voltage-dependent T-type calcium channel subunit alpha-1H": 794, "Multidrug resistance protein 1": 795, "NAD kinase 1": 796, "UDP-galactopyranose mutase": 797, "Sodium/nucleoside cotransporter": 798, "Fibroblast growth factor receptor 2": 799, "BDNF/NT-3 growth factors receptor": 800, "Peptidyl-prolyl cis-trans isomerase FKBP1A": 801, "Voltage-dependent L-type calcium channel subunit beta-2": 802, "Neuropeptide Y receptor type 4": 803, "Farnesyl pyrophosphate synthase": 804, "Queuine tRNA-ribosyltransferase": 805, "Corticotropin-releasing factor receptor 2": 806, "Kappa-type opioid receptor [K227A]": 807, "Caspase-2": 808, "Matrix metalloproteinase-14 [1-20,P8S]": 809, "Neuronal acetylcholine receptor subunit alpha-9": 810, "Cholinergic receptor nicotinic alpha 5 subunit": 811, "Baculoviral IAP repeat-containing protein 2 [266-354]": 812, "Isoform 3 of Ribosomal protein S6 kinase alpha-2 (3)": 813, "Ninein": 814, "D(2) dopamine receptor": 815, "Mitogen-activated protein kinase 9": 816, "Potassium voltage-gated channel subfamily A member 1": 817, "Phosphodiesterase 3a": 818, "Mast/stem cell growth factor receptor Kit": 819, "Serine/threonine-protein phosphatase 2A activator": 820, "Alpha-glucosidase MAL12": 821, "Orotidine-5'-phosphate decarboxylase": 822, "Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1": 823, "Nanos homolog 2": 824, "Neuropeptide Y receptor type 1": 825, "Calcium/calmodulin-dependent protein kinase type II subunit beta": 826, "DNA polymerase subunit gamma-1": 827, "Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,M535I,L552P,A560V,V571A,I573V,L579M]": 828, "Receptor-type tyrosine-protein phosphatase C": 829, "Bile salt export pump": 830, "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform": 831, "D(1A) dopamine receptor": 832, "cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A": 833, "Oxysterols receptor LXR-alpha": 834, "Fatty acid-binding protein, liver": 835, "Lysine-specific histone demethylase 1A": 836, "Cathepsin L": 837, "Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,L552P,A560V,V571A,I573V,L579M]": 838, "Carbonic anhydrase 9": 839, "Tyrosine-protein phosphatase non-receptor type 13": 840, "Inositol-trisphosphate 3-kinase A": 841, "Somatostatin receptor type 3": 842, "Renin": 843, "N(G),N(G)-dimethylarginine dimethylaminohydrolase 1": 844, "Bifunctional aspartokinase/homoserine dehydrogenase 1": 845, "Aldo-keto reductase family 1 member C1 [L54V]": 846, "Hepatocyte growth factor receptor [1078-1345,M1250T,L1272V]": 847, "Vitamin D3 receptor": 848, "Tyrosine-protein kinase JAK1": 849, "Calcium release-activated calcium channel protein 1": 850, "Aldo-keto reductase family 1 member C1 [H222S]": 851, "Oxytocin receptor": 852, "Phenylethanolamine N-methyltransferase": 853, "Salicylate synthase": 854, "Beta-lactamase": 855, "Sodium-dependent noradrenaline transporter": 856, "Alpha-carbonic anhydrase domain-containing protein": 857, "Urease": 858, "Glutathione-disulfide reductase": 859, "Histone deacetylase 6 [440-798]": 860, "Urokinase-type plasminogen activator": 861, "Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,M535I,L552P,A560V,V571A,L579M]": 862, "dCTP pyrophosphatase 1": 863, "Kappa-type opioid receptor [Y312F]": 864, "Serine/threonine-protein kinase Sgk1": 865, "Galanin receptor type 3": 866, "C-C chemokine receptor type 5": 867, "Acetylcholine-binding protein": 868, "Vitamin K epoxide reductase complex subunit 1-like protein 1": 869, "Beta-lactamase TEM": 870, "Metabotropic glutamate receptor 3": 871, "Dipeptidyl peptidase 4": 872, "Solute carrier family 22 member 1": 873, "Ribosomal protein S6 kinase alpha-4": 874, "Alpha-1A adrenergic receptor": 875, "Dimer of Gag-Pol polyprotein [489-587,I573V]": 876, "Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase": 877, "Trehalose synthase/amylase TreS": 878, "Neurotensin receptor type 2": 879, "Soluble acetylcholine receptor": 880, "Aurora kinase A": 881, "Plasmepsin II": 882, "Amine oxidase [flavin-containing] B": 883, "Kappa-type opioid receptor [I135A]": 884, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,F554C]": 885, "ATP receptor": 886, "Aryl hydrocarbon receptor": 887, "Kappa-type opioid receptor [Y119A]": 888, "Polyphenol oxidase 1 [N65D,S176D,K211T,P277A,P406L]": 889, "Beta-hexosaminidase subunit alpha": 890, "Angiotensin-converting enzyme": 891, "Aromatase": 892, "Nitric oxide synthase, endothelial [N368D]": 893, "Transmembrane and immunoglobulin domain-containing 3": 894, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,K555C]": 895, "Orotidine 5'-phosphate decarboxylase": 896, "Nitric oxide synthase, brain [D597N]": 897, "2'-deoxynucleoside 5'-phosphate N-hydrolase 1": 898, "Prostacyclin receptor": 899, "ATP-sensitive inward rectifier potassium channel 11": 900, "Cytosol aminopeptidase": 901, "Alpha-mannosidase 2": 902, "Estrogen receptor": 903, "Metabotropic glutamate receptor 6": 904, "UDP-3-O-acyl-N-acetylglucosamine deacetylase": 905, "C-C chemokine receptor type 1": 906, "Glutamate receptor 4": 907, "Protein arginine N-methyltransferase 3 [N508S]": 908, "5-hydroxytryptamine receptor 3A": 909, "Liver carboxylesterase 1": 910, "Glutamine--fructose-6-phosphate aminotransferase [isomerizing]": 911, "Trace amine-associated receptor 7b": 912, "Acyl-protein thioesterase 2 [L78I,A85S,P86Q]": 913, "Urokinase-type plasminogen activator [179-431,I214M,N322A,S371A]": 914, "Kappa-type opioid receptor [Y139A]": 915, "Cannabinoid receptor 2": 916, "Muscarinic acetylcholine receptor M5": 917, "Protein phosphatase 3 catalytic subunit alpha": 918, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,L591M]": 919, "Dimer of Gag-Pol polyprotein [501-599]": 920, "Arachidonate 12-lipoxygenase, 12R-type": 921, "RAC-alpha serine/threonine-protein kinase": 922, "Retinoic acid receptor alpha [200-419]": 923, "Signal transducer and activator of transcription 3 [127-722]": 924, "Carbonic anhydrase": 925, "Ribosomal protein S6 kinase alpha-2": 926, "Homoisocitrate dehydrogenase, mitochondrial": 927, "Coagulation factor XII": 928, "Protein kinase C beta type": 929, "Metabotropic glutamate receptor 2": 930, "Type-1 angiotensin II receptor A": 931, "Acyl-protein thioesterase 1 [I75L,S82A,Q83P]": 932, "Uncharacterized protein": 933, "Calcium-activated potassium channel subunit beta": 934, "Prothrombin": 935, "5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase": 936, "Bifunctional purine biosynthesis protein ATIC": 937, "Arginine vasopressin-induced protein 1": 938, "5-hydroxytryptamine receptor 5A": 939, "Hematopoietic prostaglandin D synthase": 940, "DNA polymerase III subunit alpha": 941, "Polycystin-1": 942, "5-hydroxytryptamine receptor 6": 943, "Calpain-1 catalytic subunit": 944, "Anthranilate phosphoribosyltransferase": 945, "Neurotensin": 946, "Serine/threonine-protein kinase pim-3": 947, "Baculoviral IAP repeat-containing protein 3 [238-349]": 948, "Sphingosine 1-phosphate receptor 2": 949, "Vesicle amine transport protein 1 homolog (T. californica)-like": 950, "Growth hormone secretagogue receptor type 1 [E24Q]": 951, "Voltage-dependent L-type calcium channel subunit alpha-1C": 952, "Prolyl 4-hydroxylase subunit alpha-1": 953, "Sodium channel protein type 10 subunit alpha": 954, "Isochorismatase domain-containing protein": 955, "Cholinesterase": 956, "Acetylcholine receptor subunit alpha": 957, "Histone deacetylase 2": 958, "Proto-oncogene tyrosine-protein kinase LCK": 959, "5-hydroxytryptamine receptor 2A": 960, "Thyroid hormone receptor alpha": 961, "Kappa-type opioid receptor [Y312A]": 962, "Complex of Baculoviral IAP repeat-containing protein 7 [63-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]": 963, "Excitatory amino acid transporter 1": 964, "Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI": 965, "Choline O-acetyltransferase": 966, "Rho-associated protein kinase 1 [17-535]": 967, "5-hydroxytryptamine receptor 5B": 968, "Baculoviral IAP repeat-containing protein 2 [269-336]": 969, "Dimer of Gag-Pol polyprotein [501-599,A572V]": 970, "Dimer of Gag-Pol polyprotein [501-599,V583F]": 971, "Bromodomain-containing protein 4 [57-168]": 972, "Calcitonin gene-related peptide 1": 973, "Metabotropic glutamate receptor 5": 974, "Tyrosine-protein kinase ZAP-70": 975, "Bombesin receptor subtype-3": 976, "Calcium-activated potassium channel subunit beta-1": 977, "Corticotropin-releasing factor receptor 1": 978, "Isoform 1 of Metabotropic glutamate receptor 5 (5a)": 979, "Acyl-protein thioesterase 1 [L176M]": 980, "Caspase-4": 981, "Collagenase ColG": 982, "Baculoviral IAP repeat-containing protein 3 [252-340]": 983, "Gastrin-releasing peptide receptor": 984, "Solute carrier organic anion transporter family member [3-691]": 985, "Dipeptidase 1": 986, "Dimer of Gag-Pol polyprotein [489-587,K509R,V521I,L522F,M525I,I543V,L552P,A560V,V571A,L579M]": 987, "Cytoplasmic tyrosine-protein kinase BMX": 988, "Bifunctional dihydrofolate reductase-thymidylate synthase [1-238,S58R,S117N]": 989, "Low molecular weight protein-tyrosine phosphatase A": 990, "Monocarboxylate transporter 1": 991, "Baculoviral IAP repeat-containing protein 2 [253-363]": 992, "Tyrosine-protein kinase ITK/TSK": 993, "Sphingosine 1-phosphate receptor 3": 994, "Beta-carbonic anhydrase 1": 995, "Gag-Pol polyprotein [484-582,I497V,V499I,E519D,R541K,D544E,Q553K,A555V,G557S,I568V,L574M,L573M]": 996, "Plasmepsin I": 997, "Hepatocyte growth factor receptor": 998, "Adenosine deaminase": 999, "Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial": 1000, "Voltage-dependent calcium channel gamma-1 subunit": 1001, "Prunasin hydrolase": 1002, "Glucagon receptor": 1003, "Tyrosine-protein phosphatase non-receptor type 1 [1-298]": 1004, "Dihydrofolate reductase [F98Y]": 1005, "CB1 cannabinoid receptor-interacting protein 1": 1006, "Prokineticin receptor 2": 1007, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,R176C]": 1008, "Neutrophil collagenase": 1009, "Nitric oxide synthase, inducible": 1010, "Plasminogen": 1011, "3-oxoacyl-[acyl-carrier-protein] synthase 1": 1012, "Tyrosine-protein kinase Lyn": 1013, "Histone-arginine methyltransferase CARM1": 1014, "Histamine H3 receptor": 1015, "Nitric oxide synthase, endothelial": 1016, "Acyl-protein thioesterase 1 [I75L,S82A,Q83P,R149H,A150R,S151A]": 1017}